{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T13:39:06Z","timestamp":1771076346947,"version":"3.50.1"},"reference-count":10,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"US CDC through a Cooperative Agreement"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Despite coordinated efforts at global level, through the Global Polio Eradication Initiative (GPEI), poliomyelitis disease (Polio) is still a major public health issue. The wild poliovirus type-1 (WPV1) is still endemic in Afghanistan and Pakistan, and new circulations of the WPV1 were confirmed in southeast Africa in 2021, in Malawi and Mozambique. The circulating vaccine derived polioviruses (cVDPV) are also causing outbreaks worldwide. The Task Force for Global Health (TFGH)\u2019s Polio Surge Capacity Support Program, established in 2019, is an effort to reinforce the existing partnership with the GPEI to strengthen countries\u2019 capacities for polio outbreak preparedness and response. In four years, its coordinated efforts with GPEI partners have resulted in a remarkable improvement in the early detection of poliovirus circulation and reducing the missed children gaps in many countries. However, these encouraging results cannot hide an increasingly complex programmatic environment with numerous funding and operational challenges.<\/jats:p>","DOI":"10.3390\/pathogens13050377","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T03:30:49Z","timestamp":1714534249000},"page":"377","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Polio Surge Capacity Support Program Contributions to Building Country Capacities in Support of Polio Outbreak Preparedness and Response: Lessons Learned and Remaining Challenges"],"prefix":"10.3390","volume":"13","author":[{"given":"Fikru","family":"Abebe","sequence":"first","affiliation":[{"name":"Polio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Anochieboh","family":"Eboh","sequence":"additional","affiliation":[{"name":"Polio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesfin Belew","family":"Weldetsadik","sequence":"additional","affiliation":[{"name":"Polio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahima","family":"Kone","sequence":"additional","affiliation":[{"name":"Polio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessema Assegid","family":"Kebede","sequence":"additional","affiliation":[{"name":"Polio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Thomas","family":"Harries","sequence":"additional","affiliation":[{"name":"Global Security Department (GSD), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veh Kesse Fabien","family":"Diomande","sequence":"additional","affiliation":[{"name":"Polio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0891-5520(05)70267-1","article-title":"Poliomyelitis eradication: Progress, challenges for the end game, and preparation for the post-eradication era","volume":"15","author":"Sutter","year":"2001","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S540","DOI":"10.1093\/infdis\/jiu345","article-title":"Global Polio Eradication Initiative: Lesson learned and legacy","volume":"210","author":"Cochi","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/infdis\/jiu222","article-title":"The new polio eradication end game: Rationale and supporting evidence","volume":"210","author":"Sutter","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_4","unstructured":"Global Polio Eradication Initiative (2021). Polio Eradication Strategy 2022\u20132026, World Health Organization."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.15585\/mmwr.mm7034a1","article-title":"Progress Toward Polio Eradication\u2014Worldwide, January 2019\u2014June 2021","volume":"70","author":"Bigouette","year":"2021","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_6","first-page":"72","article-title":"Update on Wild Poliovirus Type 1 Outbreak\u2014Southeastern Africa, 2021\u20132022","volume":"14","author":"Davlantes","year":"2023","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.15585\/mmwr.mm7219a3","article-title":"Progress Toward Poliomyelitis Eradication\u2014Worldwide, January 2021\u2013March 2023","volume":"72","author":"Lee","year":"2023","journal-title":"Morb Mortal Wkly Rep."},{"key":"ref_8","unstructured":"(2023, December 28). GPEI Global Circulating Vaccine Derived Polio Virus (cVDPV). Available online: https:\/\/polioeradication.org\/wp-content\/uploads\/2024\/04\/weekly-polio-analyses-cVDPV-20240423.pdf."},{"key":"ref_9","unstructured":"Global Polio Eradication Initiative (2020). Standard Operating Procedures, Responding to a Poliovirus Event or Outbreak, World Health Organization. Version 3.1."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"A142","DOI":"10.1016\/j.vaccine.2022.10.060","article-title":"Outbreak response strategies with type 2\u2014Containing oral poliovirus vaccines","volume":"41","author":"Kalkowska","year":"2023","journal-title":"Vaccine"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/5\/377\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:37:58Z","timestamp":1760107078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/13\/5\/377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["pathogens13050377"],"URL":"https:\/\/doi.org\/10.3390\/pathogens13050377","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]}}}